PERSISTENT B19 PARVOVIRUS INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - A TREATABLE CAUSE OF ANEMIA IN AIDS

被引：375

作者：

FRICKHOFEN, N

ABKOWITZ, JL

SAFFORD, M

BERRY, JM

ANTUNEZDEMAYOLO, J

ASTROW, A

COHEN, R

HALPERIN, I

KING, L

MINTZER, D

COHEN, B

YOUNG, NS

机构：

[1] NHLBI, BLDG 10-7C103, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA

[2] UNIV WASHINGTON, SCH MED, SEATTLE, WA 98195 USA

[3] BROWN UNIV, MIRIAM HOSP, PROVIDENCE, RI 02912 USA

[4] PACIFIC PRESBYTERIAN MED CTR, SAN FRANCISCO, CA USA

[5] UNIV MIAMI, SCH MED, MIAMI, FL 33152 USA

[6] ST VINCENTS HOSP & MED CTR, NEW YORK, NY 10011 USA

[7] PENN HOSP, PHILADELPHIA, PA 19107 USA

[8] CENT PUBL HLTH LAB, LONDON NW9 5HT, ENGLAND

来源：

ANNALS OF INTERNAL MEDICINE | 1990年 / 113卷 / 12期

关键词：

D O I：

10.7326/0003-4819-113-12-926

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The B19 parvovirus is a remediable cause of severe chronic anemia in HIV-infected patients. Recognition of and therapy for parvovirus in this population will avoid erythrocyte transfusion and should prevent transmission of the virus to other persons, including immunosuppressed persons and women of childbearing age.

引用

页码：926 / 933

页数：8

共 40 条

[1] FOLIC ACID DEFICIENCY COMPLICATING SICKLE CELL ANEMIA - A STUDY ON RESPONSE TO TITRATED DOSES OF FOLIC ACID [J].